Dr. Martin Griessl

” Lysando AG is a technological leader in the field of antimicrobial proteins, which are used to combat multidrug resistant bacteria. Central goals of our protein design and formulation are the correct folding and a high stability of these proteins. Next to CD spectroscopy, we use nanoDSF analyses performed by the experienced team of 2bind in order to gain insights into the desired protein parameters. Beside the fast realization and the low sample consumption, we are impressed by the great consistency of both methods. The highly reproducible nanoDSF data provided important information on the stability of our proteins under diverse buffer conditions.”

Dr. Martin Griessl, Senior Scientist, Lysando AG, Regensburg, Germany